Skip to content
Home › 13F recaps › Q3 2026 › AZN

Which funds bought or sold AZN in Q3 2026?

Astrazeneca Plc. 10 funds bought, 7 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was +$608M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold AZN, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (10)

FundChangeEst. $Now
D. E. Shaw
Quant & multi-strategy
Added+336.3%+$594M$771M
Wellington
Asset manager
Added+8.1%+$374M$5.0B
Capital Research
Asset manager
Added+27%+$185M$867M
Capital World
Asset manager
Added+3.4%+$165M$5.1B
Point72
Quant & multi-strategy
Added+134.4%+$154M$269M
State Street
Index giant
Added+283.7%+$119M$161M
Amundi
Asset manager
Added+4.3%+$113M$2.8B
Marshall Wace
Quant & multi-strategy
Added+75.6%+$103M$238M
Temasek
Sovereign & pension
Added+77.3%+$70M$160M
Fisher Investments
Asset manager
Added+3.2%+$57M$1.9B

Sold (7)

FundChangeEst. $Now
Ameriprise
Asset manager
Trimmed-15.8%−$155M$828M
AllianceBernstein
Asset manager
Trimmed-18.6%−$132M$576M
Northern Trust
Bank & broker
Trimmed-17.7%−$66M$307M
Jennison
Growth / crossover
Trimmed-28.9%−$31M$77M
Farallon
Hedge fund
Trimmed-23.3%−$22M$71M
Glenview
Hedge fund
Trimmed-31.8%−$9M$20M
GQG
Growth / crossover
Trimmed-85.4%−$6M$1M

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.